Bone Marrow Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
45
NCT06961383
Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 1, 2025
Completion: Mar 1, 2028
Loading map...